Sort
130,381 grants matching “hiv”
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$4,216,430Judith S. Currier · University Of California Los Angeles · UM1 · FY2012 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$4,215,691Ken Palermo · Missouri State Dept/ Health & Senior Srv · U62 · FY2012 · PS
UAB-ZAMBIA-HAITI HIV PREVENTION TRIALS UNIT
$4,214,816University Of Alabama At Birmingham · U01 · FY2002 · AI
Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine
$4,212,877Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2009 · AI
Development And Production Of A Multiclade HIV-1 DNA Plasmid Vaccine
$4,212,877Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2009 · AI
Rationally designed targeted immunogens to elicit HIV Envelope V2-apex broadly neutralizing antibodies
$4,211,839Raiees Ahmad Andrabi · University Of Pennsylvania · U19 · FY2025 · AI
Structural Biology Center for HIV/Host Interactions in Trafficking and Assembly
$4,210,586Wesley Ian Sundquist · University Of Utah · P50 · FY2016 · GM
Community-Based HIV VCT: South Africa
$4,209,595Thomas J. Coates · University Of California Los Angeles · U01 · FY2009 · MH
The University of North Carolina Center for AIDS Research
$4,209,183Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2021 · AI
Development of rationally designed HIV vaccines
$4,206,398Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Small molecule inhibitors of enveloped virus entry
$4,204,548Sean P. J. Whelan · Harvard Medical School · U19 · FY2015 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$4,203,388Ralph Wilmoth · Colorado State Dept/Pub Hlth & Environmt · U62 · FY2014 · PS
Optimizing the Immunogenicity of MVA-Based AIDS Vaccines
$4,202,132Emory University · U19 · FY2005 · AI
Washington Women's Interagency HIV/AIDS Study
$4,201,485Mary A Young · Georgetown University · U01 · FY2014 · AI
Studies of HIV infection and its contribution to the natural history and outcome
$4,200,474Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
PARTNERS IN HEALTH/ZANMI LASANTE: STRENGTHENING INTEGRATED HIV AND CHOLERA CARE,
$4,200,000Mukherjee Joia · Partners In Health · U2G · FY2012 · GH
IMPROVEMENT OF INTEGRATED HIV CLINICAL-BASED SERVICES
$4,200,000Jean William Pape · Gheskio Center · U2G · FY2012 · GH
PROVISION OF MEDICAL MALE CIRCUMCISION (MMC) FOR HIV PREVENTION IN KWAZULU NATAL
$4,200,000Colleen Khumalo · Sactwu Aids Project · U2G · FY2014 · GH
Meharry Clinical and Translational Research Center (MeTRC)
$4,199,944Samuel E. Adunyah · Meharry Medical College · U54 · FY2012 · MD
cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine
$4,199,938Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2021 · AI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$4,197,323Pamela J Bjorkman · California Institute Of Technology · P01 · FY2024 · AI
HIV PREVENTION TRIAL UNIT
$4,196,356University Of Pennsylvania · U01 · FY2004 · AI
CPCRA Clinical Trials Unit
$4,195,685Fred M Gordin · George Washington University · UM1 · FY2013 · AI
Chicago Chronic Condition Equity Network (C3EN)
$4,195,279Elbert S. Huang · University Of Chicago · P50 · FY2021 · MD
Harvard University Center for AIDS Research
$4,195,217Bruce D Walker · Harvard University · P30 · FY2012 · AI